FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:1507-1508 October 5, 2006 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

Edited by D. Virgil Alfaro III, Peter E. Liggett, William F. Mieler, Hugo Quiroz-Mercado, Rama D. Jager, and Yasuo Tano. 364 pp., illustrated. Philadelphia, Lippincott Williams & Wilkins, 2006. $159. ISBN 0-7817-3899-7.

In the spectrum of eye diseases, few rival age-related macular degeneration. Moderately advanced dry macular degeneration alone is estimated to affect more than 8 million Americans over 55 years of age. Age-related macular degeneration is the leading cause of vision loss in developed nations, accounting for more than 50% of the cases of blindness, and it has a profound effect on the quality of life — some legally blind patients with the condition have been known to say they would give up 50% of their remaining years in exchange for perfect vision.

There has been a considerable effort to find . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.